Michel Roussey

1.4k total citations
34 papers, 940 citations indexed

About

Michel Roussey is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Michel Roussey has authored 34 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 5 papers in Psychiatry and Mental health. Recurrent topics in Michel Roussey's work include Cystic Fibrosis Research Advances (23 papers), Neonatal Respiratory Health Research (16 papers) and Tracheal and airway disorders (9 papers). Michel Roussey is often cited by papers focused on Cystic Fibrosis Research Advances (23 papers), Neonatal Respiratory Health Research (16 papers) and Tracheal and airway disorders (9 papers). Michel Roussey collaborates with scholars based in France, United Kingdom and United States. Michel Roussey's co-authors include À. Munck, Virginie Scotet, Claude Férec, G. Rault, Marie‐Pierre Audrézet, David Cheillan, Juliane Léger, Dominique Delmas, Annick Clément and Cyril Flamant and has published in prestigious journals such as The Lancet, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michel Roussey

33 papers receiving 915 citations

Peers

Michel Roussey

PRM

PPCH

EDM

GENET

Diwakar D. Balachandran United States

Iliana Bersani Italy

Ali Atan Türkiye

Mariarosaria Di Tommaso Italy

Meharban Singh India

Dan K. Seilheimer United States

Edith Collins Australia

L. Foix‐L’Hélias France

Claude Sureau France

Mary K. Miller United States

Diwakar D. Balachandran United States

Michel Roussey

252 ×0.4

PRM

74 ×0.5

PPCH

77 ×0.7

EDM

39 ×0.4

42 ×0.4

GENET

Citations per year, relative to Michel Roussey Michel Roussey (= 1×) peers Diwakar D. Balachandran

Countries citing papers authored by Michel Roussey

Since Specialization

Citations

This map shows the geographic impact of Michel Roussey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Roussey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Roussey more than expected).

Fields of papers citing papers by Michel Roussey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Roussey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Roussey. The network helps show where Michel Roussey may publish in the future.

Co-authorship network of co-authors of Michel Roussey

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Roussey. A scholar is included among the top collaborators of Michel Roussey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Roussey. Michel Roussey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Caroline, Isabelle Durand‐Zaleski, J. Frenkiel, et al.. (2019). Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results. Clinical Immunology. 202. 33–39. 29 indexed citations

Sarles, Jacques, Roch Giorgi, Patrice Berthézène, et al.. (2014). Neonatal screening for cystic fibrosis: Comparing the performances of IRT/DNA and IRT/PAP. Journal of Cystic Fibrosis. 13(4). 384–390. 34 indexed citations

Munck, À., Virginie Scotet, Mireille Claustres, et al.. (2014). Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy. Genetics in Medicine. 17(2). 108–116. 33 indexed citations

Duguépéroux, I., Marie‐Pierre Audrézet, Philippe Parent, et al.. (2012). Cascade testing in families of carriers identified through newborn screening in Western Brittany (France). Journal of Cystic Fibrosis. 12(4). 338–344. 1 indexed citations

Proisy, Maïa, Philippe Loget, Renaud Bouvet, et al.. (2012). Whole-body post-mortem computed tomography compared with autopsy in the investigation of unexpected death in infants and children. European Radiology. 23(6). 1711–1719. 63 indexed citations

Scotet, Virginie, I. Duguépéroux, Philippe Saliou, et al.. (2012). Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France. Orphanet Journal of Rare Diseases. 7(1). 14–14. 41 indexed citations

Roussey, Michel, et al.. (2011). Formative evaluation to improve prevention of sudden infant death syndrome (SIDS): a prospective study. Acta Paediatrica. 100(10). e147–51. 11 indexed citations

Léger, Juliane, et al.. (2011). Subtle Health Impairment and Socioeducational Attainment in Young Adult Patients with Congenital Hypothyroidism Diagnosed by Neonatal Screening: A Longitudinal Population-Based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1771–1782. 59 indexed citations

Beucher, J., Emmanuelle Leray, Eric Deneuville, et al.. (2010). Psychological Effects of False-Positive Results in Cystic Fibrosis Newborn Screening: A Two-Year Follow-Up. The Journal of Pediatrics. 156(5). 771–776.e1. 43 indexed citations

10.

Munck, À., et al.. (2009). The Importance of Sweat Testing for Older Siblings of Patients with Cystic Fibrosis Identified by Newborn Screening. The Journal of Pediatrics. 155(6). 928–930.e1. 12 indexed citations

11.

Dauman, R, Michel Roussey, Françoise Denoyelle, et al.. (2009). Screening to detect permanent childhood hearing impairment in neonates transferred from the newborn nursery. International Journal of Pediatric Otorhinolaryngology. 73(3). 457–465. 15 indexed citations

12.

Munck, À., et al.. (2008). Implementation of the French Nationwide Cystic Fibrosis Newborn Screening Program. The Journal of Pediatrics. 153(2). 228–233.e1. 49 indexed citations

13.

Munck, À., Thierry Lamireau, B. Le Luyer, et al.. (2008). Pancreatic enzyme replacement therapy for young cystic fibrosis patients. Journal of Cystic Fibrosis. 8(1). 14–18. 31 indexed citations

14.

Roussey, Michel & Eric Deneuville. (2005). Mise au point sur le dépistage néonatal de la mucoviscidose. MTP. Médecine thérapeutique pédiatrie. 8(3). 156–165.

15.

Flamant, Cyril, Alexandra Henrion‐Caude, Jacques Brouard, et al.. (2004). Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis. Pharmacogenetics. 14(5). 295–301. 36 indexed citations

16.

Scotet, Virginie, Marie‐Pierre Audrézet, Michel Roussey, et al.. (2003). Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France. Human Genetics. 113(3). 280–285. 20 indexed citations

17.

Henrion‐Caude, Alexandra, Cyril Flamant, Michel Roussey, et al.. (2002). Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology. 36(4). 913–917. 59 indexed citations

18.

Roussey, Michel, et al.. (2001). Les certificats médicaux obligatoires de la première enfance : un outil épidémiologique méconnu. Bulletin de l Académie Nationale de Médecine. 185(4). 727–747. 7 indexed citations

19.

Scotet, Virginie, Marc De Braekeleer, Michel Roussey, et al.. (2000). Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis. The Lancet. 356(9232). 789–794. 85 indexed citations

20.

Deneuville, Eric, Michel Roussey, Jean‐Marie Zahm, et al.. (1997). Revisited Physicochemical and Transport Properties of Respiratory Mucus in Genotyped Cystic Fibrosis Patients. American Journal of Respiratory and Critical Care Medicine. 156(1). 166–172. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact